Trials / Completed
CompletedNCT00102479
Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents
A Phase II Study to Test PK Tolerability in Children and Adolescents
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
- Sex
- All
- Age
- 10 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to assess the safety, tolerability and pharmacokinetics of aripiprazole tablets following oral administration to children and adolescents.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aripiprazole |
Timeline
- Start date
- 2004-07-01
- Completion
- 2005-07-01
- First posted
- 2005-01-31
- Last updated
- 2006-04-17
Source: ClinicalTrials.gov record NCT00102479. Inclusion in this directory is not an endorsement.